Increased STAT3 mRNA expression had no effect on OS for all ovarian cancer patients, HR =0.85 (0.68–1.06), P=0.14 (Figure 3A), as well as serous cancer patients, HR =0.85 (0.66–1.09), P=0.2 (Figure 3B). This evidence concerns the gene STAT3 and ovarian cancer.